Pages that link to "Q30651053"
Jump to navigation
Jump to search
The following pages link to Structural characterization of the circulating soluble FGF receptors reveals multiple isoforms generated by secretion and ectodomain shedding (Q30651053):
Displayed 19 items.
- Fibulin-3 negatively regulates chondrocyte differentiation (Q22001511) (← links)
- Characterization of the NPGP receptor and identification of a novel short mRNA isoform in human hypothalamus (Q28212650) (← links)
- Prox1 promotes lineage-specific expression of fibroblast growth factor (FGF) receptor-3 in lymphatic endothelium: a role for FGF signaling in lymphangiogenesis (Q28587821) (← links)
- Organically modified silica nanoparticles: a nonviral vector for in vivo gene delivery and expression in the brain (Q30476054) (← links)
- Design of growth factor sequestering biomaterials (Q34543371) (← links)
- Transmodulation of cell surface regulatory molecules via ectodomain shedding (Q34584816) (← links)
- Ligand activation leads to regulated intramembrane proteolysis of fibroblast growth factor receptor 3 (Q35340703) (← links)
- Targeting the heparin-binding domain of fibroblast growth factor receptor 1 as a potential cancer therapy (Q35881055) (← links)
- FGFR1 cleavage and nuclear translocation regulates breast cancer cell behavior (Q36027395) (← links)
- Phosphorylation and lipid raft association of fibroblast growth factor receptor-2 in oligodendrocytes (Q37193581) (← links)
- The Fgfr2 W290R mouse model of Crouzon syndrome (Q38032781) (← links)
- Isoforms of receptors of fibroblast growth factors (Q38204716) (← links)
- Developmental pathways hijacked by osteosarcoma (Q38219835) (← links)
- Xeno-Klotho Inhibits Parathyroid Hormone Signaling (Q38842548) (← links)
- A soluble form of fibroblast growth factor receptor 2 (FGFR2) with S252W mutation acts as an efficient inhibitor for the enhanced osteoblastic differentiation caused by FGFR2 activation in Apert syndrome (Q39692110) (← links)
- Activation of FGFR1beta signaling pathway promotes survival, migration and resistance to chemotherapy in acute myeloid leukemia cells (Q40295205) (← links)
- Identification and characterization of an inhibitory fibroblast growth factor receptor 2 (FGFR2) molecule, up-regulated in an Apert Syndrome mouse model (Q45345173) (← links)
- Characterization of FGF receptor expression in human neutrophils and their contribution to chemotaxis. (Q54571394) (← links)
- Validation of a Novel Modified Aptamer-Based Array Proteomic Platform in Patients with End-Stage Renal Disease (Q57294144) (← links)